Squarepoint Ops LLC Takes Position in United States Antimony Co. (NYSE:UAMY)

Squarepoint Ops LLC purchased a new position in shares of United States Antimony Co. (NYSE:UAMY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 117,882 shares of the company's stock, valued at approximately $209,000. Squarepoint Ops LLC owned approximately 0.11% of United States Antimony as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Kingsview Wealth Management LLC purchased a new stake in United States Antimony during the fourth quarter worth about $35,000. Cetera Investment Advisers acquired a new stake in shares of United States Antimony during the 4th quarter valued at approximately $40,000. Tower Research Capital LLC TRC boosted its stake in shares of United States Antimony by 2,205.1% during the 4th quarter. Tower Research Capital LLC TRC now owns 26,716 shares of the company's stock worth $47,000 after acquiring an additional 25,557 shares in the last quarter. Jefferies Financial Group Inc. purchased a new stake in shares of United States Antimony during the 4th quarter worth approximately $52,000. Finally, Financial Sense Advisors Inc. acquired a new stake in shares of United States Antimony in the 4th quarter worth approximately $53,000. Institutional investors and hedge funds own 9.49% of the company's stock.

United States Antimony Price Performance

UAMY stock opened at $3.37 on Monday. The stock's 50 day moving average price is $2.84 and its 200 day moving average price is $2.07. The firm has a market cap of $401.30 million, a P/E ratio of -84.25 and a beta of 0.07. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.84 and a current ratio of 6.24. United States Antimony Co. has a 1 year low of $0.27 and a 1 year high of $3.86.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on UAMY. D. Boral Capital reaffirmed a "buy" rating and set a $5.00 price objective on shares of United States Antimony in a report on Monday, May 12th. Wall Street Zen cut United States Antimony from a "hold" rating to a "sell" rating in a research report on Thursday, May 15th. B. Riley reaffirmed a "buy" rating on shares of United States Antimony in a research note on Tuesday, April 15th. D Boral Capital upgraded shares of United States Antimony to a "strong-buy" rating in a research report on Wednesday, April 23rd. Finally, HC Wainwright increased their price objective on shares of United States Antimony from $2.60 to $4.50 and gave the company a "buy" rating in a research note on Friday, May 9th. One analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $3.38.

About United States Antimony

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.

Want to see what other hedge funds are holding UAMY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for United States Antimony Co. (NYSE:UAMY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.